CC
BBNX

Centiva Capital’s Beta Bionics BBNX Stock Holding History

Centiva Capital’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-39,157
Closed -$392K – 2292
2026
Q1 		$392K Buy
+39,157
New +$579K ﹤0.01% 952
2025
Q4 		– Sell
-19,903
Closed -$395K – 1668
2025
Q3 		$395K Buy
19,903
+5,357
+37% +$94.1K ﹤0.01% 705
2025
Q2 		$212K Sell
14,546
-5,585
-28% -$79.1K ﹤0.01% 1314
2025
Q1 		$246K Buy
+20,131
New +$375K 0.01% 1186

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Centiva Capital's BBNX Position: Q2 2026 in Review

Centiva Capital sold out of Beta Bionics (BBNX) in Q2 2026, closing a stake of 39,157 shares — an estimated $392K sold.

Centiva Capital first reported a position in BBNX in Q1 2025 and held it in 4 quarters. The position peaked at $395K in Q3 2025. 134 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Centiva Capital reported no remaining Beta Bionics position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 39,157 Beta Bionics shares in Q2 2026, an estimated $392K.
  • Centiva Capital first reported a position in Beta Bionics in Q1 2025 and held it in 4 quarters.
  • Centiva Capital's Beta Bionics position peaked at $395K in Q3 2025.
  • 134 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.